Anterior commissure involvement in early glottic carcinoma treated with radiotherapy
This is a meta-analysis and review of patients with early-stage glottic carcinoma treated with definitive radiotherapy. The study synthesized evidence on the prognostic impact of anterior commissure involvement (ACI) compared to its absence. The total sample size across included studies was 2527 patients. The setting was not reported in the source data.
The intervention or exposure was the presence of anterior commissure involvement. The comparator was the absence of anterior commissure involvement. Specific radiotherapy dosing or protocol details were not reported in the input. The primary outcome was local failure, defined as local recurrence.
In the primary analysis, the presence of ACI was significantly associated with an increased risk of local recurrence in univariate analysis. The effect size was an odds ratio (OR) of 1.61 (95% CI 1.15-2.26) with a p-value of 0.006. However, in multivariate models, the adjusted ORs ranged from 1.05 to 1.43, and the 95% credible intervals included unity, indicating no consistent significant association. The direction of effect was increased risk in univariate analysis but attenuated and non-significant in multivariate models. Absolute numbers for local recurrence events were not reported.
Key secondary outcomes were not reported in the input data. The review did not provide specific secondary outcome results or data.
Safety and tolerability findings were not reported. The input states that adverse events, serious adverse events, discontinuations, and overall tolerability were not reported. Therefore, no safety data can be presented from this synthesis.
These results can be compared to prior landmark studies in this therapeutic area, but the input does not specify which prior studies were reviewed or their findings. The review notes that the univariate findings may be confounded by correlation with other factors, and the ACI effect was not confirmed in adjusted models. The certainty note indicates that a Bayesian multivariate meta-analysis provided more robust evidence than univariate analysis.
Key methodological limitations include moderate heterogeneity (I^2 = 34%) in the univariate analysis and incomplete reporting of risk factors in some studies. Potential biases may arise from these limitations and the observational nature of the included studies. The causality note clarifies that association versus causation was not explicitly distinguished, and multivariate analysis suggests confounding by other factors, such as T substage.
Clinical implications are that ACI should not be regarded as a fundamental prognostic criterion in early-stage glottic carcinoma, based on this synthesis. Practice decisions should not rely solely on ACI status, given the attenuated effect in adjusted models. What questions remain unanswered include the specific impact of ACI in well-defined subgroups, the interaction with other tumor characteristics, and the need for prospective validation of these findings in controlled settings.